U.S. oil-field services provider Baker Hughes BKR-1.64%decrease; red down pointing triangle agreed to sell its Waygate Technologies business to Swedish industrial technology company Hexagon HEXA.B ...

April 13 (Reuters) - Baker ⁠Hughes ⁠said on Monday it ⁠will sell its unit, Waygate Technologies, to Sweden-based Hexagon for about $1.45 billion in cash, as the oilfield services provider reorganizes ...

U.S. oil-field services provider Baker Hughes agreed to sell its Waygate Technologies business to Swedish industrial technology company Hexagon for around $1.45 billion in cash, the companies said.

April 13 (Reuters) - Baker Hughes (BKR.O), opens new tab said on Monday it will sell its unit, Waygate Technologies, to Sweden-based Hexagon (HEXAb.ST), opens new tab for about $1.45 billion in cash, ...

Induced pluripotent stem cells (iPSCs) are derived from adult cells, such as skin or blood cells, which have been “reprogrammed” back to a stem-cell-like state. This transformation grants them the ...

No, this isn’t science fiction. Real-life researchers taught a dish of roughly 200,000 living human brain cells to play the classic 1990s computer game “Doom.” Experts at Cortical Labs, an Australian ...

At 2025's Nvidia GTC event, a bipedal robot named Blue fumbled around stage and disobeyed simple commands. This year at the show, Olaf the robot did better. Every year, the highlight of Nvidia’s GTC ...

A solar charging kit, inexpensive as-is and purchased after further promotional enticement, enables keeping a remotely located vehicle battery topped off. One of the things I enjoy most about ...

Dallas Mavericks' Marvin Bagley III (35) dunks against the Minnesota Timberwolves during the second half of an NBA basketball game Friday, Feb. 20, 2026, in Minneapolis. Lily Dozier / AP MINNEAPOLIS — ...

Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.